FDA Adverse Event Injury Summary report: N

VERCISE CARTESIA

MDR report key: 15279464 · Received August 23, 2022

Report

Report Number
3006630150-2022-04175
Event Type
Injury
Date Received
August 23, 2022
Date of Event
July 22, 2022
Report Date
November 8, 2022
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
NHL
UDI-DI
08714729905288
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(4), BATCH: (B)(4).

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS. UPN: M365DB2202450. MODEL: DB-2202-45. SERIAL: (B)(6). BATCH: 7092381.

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS. UPN: M365DB2202450. MODEL: DB-2202-45. SERIAL: (B)(6). BATCH: 7092381.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED MILD PERI-LEAD EDEMA RELATED TO BOTH IMPLANTED LEADS. THEREFORE, THE PATIENT WAS TREATED WITH AN ORAL STEROID. THE EDEMA WAS ASSESSED TO BE CAUSALLY RELATED TO THE PROCEDURE, DEVICE, AND STIMULATION. THE PATIENT IS CURRENTLY RECOVERING.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED MILD PERI-LEAD EDEMA RELATED TO BOTH IMPLANTED LEADS. THEREFORE, THE PATIENT WAS TREATED WITH AN ORAL STEROID. THE EDEMA WAS ASSESSED TO BE CAUSALLY RELATED TO THE PROCEDURE, DEVICE, AND STIMULATION. THE PATIENT IS CURRENTLY RECOVERING. ADDITIONAL INFORMATION WAS RECEIVED THAT THE EVENT WAS CAUSALLY RELATED TO THE PROCEDURE AND THE HARDWARE, AND NOT RELATED TO THE STIMULATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED MILD PERI-LEAD EDEMA RELATED TO BOTH IMPLANTED LEADS. THEREFORE, THE PATIENT WAS TREATED WITH AN ORAL STEROID. THE EDEMA WAS ASSESSED TO BE CAUSALLY RELATED TO THE PROCEDURE, DEVICE, AND STIMULATION. THE PATIENT IS CURRENTLY RECOVERING. ADDITIONAL INFORMATION WAS RECEIVED THAT THE EVENT WAS CAUSALLY RELATED TO THE PROCEDURE AND THE HARDWARE, AND NOT RELATED TO THE STIMULATION. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT HAD EXPERIENCED MILD DROWSINESS THEREFORE, A COMPUTERIZED TOMOGRAPHY SCAN WAS PERFORMED AND HAD CONFIRMED THE PRESENCE OF MILD PERI-LEAD EDEMA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2352872 VERCISE CARTESIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION DB-2202-45 7092829 08714729905288

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention